Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-003276-39Phase 2Completed
A Phase 2 trial of ferrous sulfate, filgrastim in polycythemia vera (PV), thrombocythemia, myeloproliferative disorder (MPD), Iron metabolism disease, sponsored by Zealand University Hospital. Started Aug 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-003276-39.